Dr. McCormick is the Chief Executive Officer of Matrix Genetics where she leads the overall strategic direction, research and operations of the industrial biotechnology company. Dr. McCormick successfully spun Matrix Genetics out of Targeted Growth, Inc. where she managed the company’s R&D operations as well as led various company-wide efforts including legislative and intellectual property strategy. Prior to joining TGI, Dr. McCormick was a partner with Integra Ventures where she led Integra’s biotechnology investment strategy and its investment in TGI. Earlier in her career she was a consultant with McKinsey & Company. Dr. McCormick earned a Ph.D. in Biology (with a focus on metabolic engineering) from the Massachusetts Institute of Technology and a BS degree from the University of Wisconsin – Madison. She is a past Chair, and current board member of the Algae Biomass Organization, the trade association for the US algae industry and the Treasurer and Executive Committee Member of the Washington Biotechnology and Biomedical Association.